Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: You Win Some, You Lose Some

J Am Coll Cardiol. 2023 Jul 4;82(1):13-15. doi: 10.1016/j.jacc.2023.05.002. Epub 2023 May 21.

¹ Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, Louisiana USA. Electronic address: hventura@ochsner.org.
² Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, Louisiana USA.
³ Center of Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Keywords: angiotensin-neprilysin inhibition; clinical trials; heart failure with preserved ejection fraction; outcomes; win ratio.

Publication types